Dorothy Elizabeth Kelly-Gemmell
Director · Viking Therapeutics, Inc.
Individual
- 2026
- Aug 7, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Dorothy Elizabeth Kelly-Gemmell files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian Lian - $14.00M in VKTX purchases and sales in the last 12 months
- Greg Zante - $2.82M in VKTX purchases and sales in the last 12 months
- Marianna Mancini - $2.73M in VKTX purchases and sales in the last 12 months
- Charles A. Rowland Jr. - $2.13M in VKTX purchases and sales in the last 12 months
- Matthew W. Foehr - $562K in VKTX purchases and sales in the last 12 months
- Neil William Aubuchon - $150K in VKTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Dorothy Elizabeth Kelly-Gemmell?
Dorothy Elizabeth Kelly-Gemmell is a corporate insider, tracked as Director of Viking Therapeutics, Inc. (VKTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Dorothy Elizabeth Kelly-Gemmell submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
